open-angle glaucoma and ocular hypertension
Ophthalmology · 2005–2015
4decisions
3medicines
1carried consumer input
0individual submissions
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| Betaxolol, Bimatoprost, Bimatoprost + Timolol, Brimonidine, Brimonidine + Timolol, Brinzolamide, Brinzolamide + Timolol, Dorzolamide, Dorzolamide + Timolol, Latanoprost, Latanoprost + Timolol, Pilocarpine, Timolol, Travoprost, Timolol + Travoprost Elevated intra-ocular pressure in patients with open-angle glaucoma or ocular hypertension, including those with inadequately controlled monotherapy requiring… | Mar 2015 | Recommended with restriction | input received |
| brinzolamide with timolol maleate Reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension not adequately controlled with monotherapy. | Mar 2010 | Recommended with restriction | no section in document |
| latanoprost with timolol maleate Reduction of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension who are insufficiently responsive to beta-blockers,… | Jul 2005 | Deferred | no section in document |
| latanoprost with timolol maleate Reduction of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension who are not adequately controlled with timolol… | Nov 2005 | Recommended with restriction | no section in document |
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 1 of 1 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.